Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats

The vasoactive peptide urotensin-II (U-II) is likely to play a key causal role in cardiac remodeling that ultimately leads to heart failure. Its contribution, specifically to the development of diastolic dysfunction and the downstream intracellular signaling, however, remains unresolved. This study...

Full description

Saved in:
Bibliographic Details
Main Authors: Tran L., Kompa A., Kemp W., Phrommintikul A., Wang B., Krum H.
Format: Journal
Published: 2017
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=74949086624&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/43360
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-43360
record_format dspace
spelling th-cmuir.6653943832-433602017-09-28T06:55:18Z Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats Tran L. Kompa A. Kemp W. Phrommintikul A. Wang B. Krum H. The vasoactive peptide urotensin-II (U-II) is likely to play a key causal role in cardiac remodeling that ultimately leads to heart failure. Its contribution, specifically to the development of diastolic dysfunction and the downstream intracellular signaling, however, remains unresolved. This study interrogates the effect of chronic U-II infusion in normal rats on cardiac structure and function. The contribution of Rho kinase (ROCK) signaling to these pathophysiological changes is evaluated in cell culture studies. Chronic high-dose U-II infusion over 4 wk signifi-cantly impaired diastolic function in rats on echocardiography-derived Doppler indexes, including E-wave deceleration time (vehicle 56.7 ± 3.3 ms, U-II 118.0 ± 21.5 ms; P < 0.01) and mitral valve annulus peak early/late diastolic tissue velocity (vehicle 2.01 ± 0.19 ms, U-II 1.04 ± 0.25 ms; P < 0.01). A lower dose of U-II infusion (1 nmol·kg -1 · h -1 ) yielded comparable changes. Diastolic dysfunction was accompanied by molecular [significant increases in procollagen-α 1 (I) gene expression on real-time PCR] and morphological (increases in total collagen, P < 0.05, and collagen type-I protein deposition, P < 0.001) evidence of left ventricular (LV) fibrosis following high-dose U-II infusion. The ROCK inhibitor GSK-576371 (10 -7 to 10 -5 M) elicited concentration-dependent inhibition of U-II (10 -7 M)-stimulated cardiac fibroblast collagen synthesis and cardiac myocyte protein synthesis. Chronic U-II infusion causes diastolic dysfunction, caused by fibrosis of the LV. The in vitro data suggest that this may be in part occurring via a ROCK-dependent pathway. Copyright © 2010 the American Physiological Society. 2017-09-28T06:55:18Z 2017-09-28T06:55:18Z 2010-01-29 Journal 03636135 2-s2.0-74949086624 10.1152/ajpheart.00942.2009 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=74949086624&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/43360
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
description The vasoactive peptide urotensin-II (U-II) is likely to play a key causal role in cardiac remodeling that ultimately leads to heart failure. Its contribution, specifically to the development of diastolic dysfunction and the downstream intracellular signaling, however, remains unresolved. This study interrogates the effect of chronic U-II infusion in normal rats on cardiac structure and function. The contribution of Rho kinase (ROCK) signaling to these pathophysiological changes is evaluated in cell culture studies. Chronic high-dose U-II infusion over 4 wk signifi-cantly impaired diastolic function in rats on echocardiography-derived Doppler indexes, including E-wave deceleration time (vehicle 56.7 ± 3.3 ms, U-II 118.0 ± 21.5 ms; P < 0.01) and mitral valve annulus peak early/late diastolic tissue velocity (vehicle 2.01 ± 0.19 ms, U-II 1.04 ± 0.25 ms; P < 0.01). A lower dose of U-II infusion (1 nmol·kg -1 · h -1 ) yielded comparable changes. Diastolic dysfunction was accompanied by molecular [significant increases in procollagen-α 1 (I) gene expression on real-time PCR] and morphological (increases in total collagen, P < 0.05, and collagen type-I protein deposition, P < 0.001) evidence of left ventricular (LV) fibrosis following high-dose U-II infusion. The ROCK inhibitor GSK-576371 (10 -7 to 10 -5 M) elicited concentration-dependent inhibition of U-II (10 -7 M)-stimulated cardiac fibroblast collagen synthesis and cardiac myocyte protein synthesis. Chronic U-II infusion causes diastolic dysfunction, caused by fibrosis of the LV. The in vitro data suggest that this may be in part occurring via a ROCK-dependent pathway. Copyright © 2010 the American Physiological Society.
format Journal
author Tran L.
Kompa A.
Kemp W.
Phrommintikul A.
Wang B.
Krum H.
spellingShingle Tran L.
Kompa A.
Kemp W.
Phrommintikul A.
Wang B.
Krum H.
Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats
author_facet Tran L.
Kompa A.
Kemp W.
Phrommintikul A.
Wang B.
Krum H.
author_sort Tran L.
title Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats
title_short Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats
title_full Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats
title_fullStr Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats
title_full_unstemmed Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats
title_sort chronic urotensin-ii infusion induces diastolic dysfunction and enhances collagen production in rats
publishDate 2017
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=74949086624&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/43360
_version_ 1681422363272413184